AI
Apeiron Investment Group Ltd. Other
US US · SEC (Form 4)
€19m
▲ Purchases (10 ops.)
Explore the complete record of transactions filed by Apeiron Investment Group Ltd.. Director active across 1 companies, notably ATAI Life Sciences N.V.. Cumulatively, 10 reports have been logged. Total volume traded: €19.3m. The latest transaction was disclosed on 20 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations 10 total
€317,528 67,703 shares @ €4.69 0.021% mcap 1.6% of flow
Common Shares
SEC:0000899243-22-016301:0 · 20 Apr 2022
Ideal exit: 15 Jan 2023 (T+270) €147,264 34,700 shares @ €4.2439 0.0099% mcap 0.8% of flow
Common Shares
SEC:0000899243-22-016117:0 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) €203,528 46,207 shares @ €4.4047 0.014% mcap 1.1% of flow
Common Shares
SEC:0000899243-22-015852:0 · 26 Apr 2022
Ideal exit: 21 Jan 2023 (T+270) €235,310 52,820 shares @ €4.4549 0.016% mcap 1.2% of flow
Common Shares
SEC:0000899243-22-015653:0 · 22 Apr 2022
Ideal exit: 17 Jan 2023 (T+270) €257,523 54,322 shares @ €4.7407 0.017% mcap 1.3% of flow
Common Shares
SEC:0000899243-22-015168:0 · 18 Apr 2022
Ideal exit: 13 Jan 2023 (T+270) €23,823 4,967 shares @ €4.7962 0.0016% mcap 0.1% of flow
Common Shares
SEC:0000899243-22-014963:0 · 14 Apr 2022
Ideal exit: 9 Jan 2023 (T+270) €248,990 55,197 shares @ €4.5109 0.017% mcap 1.3% of flow
Common Shares
SEC:0000899243-22-014797:0 · 12 Apr 2022
Ideal exit: 7 Jan 2023 (T+270) €255,540 57,689 shares @ €4.4296 0.017% mcap 1.3% of flow
Common Shares
SEC:0000899243-22-014575:0 · 8 Apr 2022
Ideal exit: 3 Jan 2023 (T+270) €9m 700,000 shares @ €12.5663 100.0% of flow
Common Shares
SEC:0000899243-21-025738 · 22 Jun 2021
Ideal exit: 19 Mar 2022 (T+270) €9m 700,000 shares @ €12.5663 0.59% mcap 45.6% of flow
Common Shares
SEC:0000899243-21-025738:0 · 22 Jun 2021
Ideal exit: 19 Mar 2022 (T+270) About Apeiron Investment Group Ltd. Apeiron Investment Group Ltd. is a director and insider at ATAI Life Sciences N.V.